Oramed Pharmaceuticals (ORMP) Institutional Ownership $2.15 +0.01 (+0.23%) As of 01:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Oramed Pharmaceuticals (NASDAQ:ORMP)CurrentInstitutional OwnershipPercentage12.73%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$6.44MNumber ofInstitutional Sellers(last 12 months)11TotalInstitutional Outflows(last 12 months)$2.02M Get ORMP Insider Trade Alerts Want to know when executives and insiders are buying or selling Oramed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ORMP Institutional Buying and Selling by Quarter Oramed Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025 Jane Street Group LLC67,173$144K0.0%+35.3%0.164% 5/13/2025 Rathbones Group PLC236,803$507K0.0%-18.3%0.580% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.87,136$186K0.0%-18.6%0.213% 5/7/2025 N.E.W. Advisory Services LLC18,900$40K0.0%+52.9%0.046% 5/7/2025 BML Capital Management LLC3,020,748$6.46M5.0%+14.3%7.395% 4/30/2025 Peapod Lane Capital LLC252,224$540K0.6%+11.0%0.617% 2/17/2025 Squarepoint Ops LLC54,439$132K0.0%-34.7%0.135% 2/17/2025 Two Sigma Investments LP110,378$267K0.0%-22.1%0.274% 2/17/2025 Two Sigma Advisers LP241,400$584K0.0%-5.6%0.599% 2/17/2025 Millennium Management LLC24,381$59K0.0%-47.8%0.060% Get the Latest News and Ratings for ORMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Bank of America Corp DE167,653$406K0.0%-2.6%0.416% 2/14/2025 Jane Street Group LLC49,663$120K0.0%-14.8%0.123% 2/14/2025 Boothbay Fund Management LLC845,188$2.05M0.1%+2.0%2.097% 2/14/2025 Dimensional Fund Advisors LP118,995$288K0.0%+143.8%0.295% 2/13/2025 Renaissance Technologies LLC151,808$367K0.0%-38.1%0.377% 2/11/2025 LPL Financial LLC17,431$42K0.0%-54.9%0.043% 2/7/2025 BML Capital Management LLC2,643,907$6.40M4.0%+20.9%6.559% 2/4/2025 World Equity Group Inc.20,000$48K0.0%N/A0.050% 1/29/2025 Peapod Lane Capital LLC227,239$550K0.5%N/A0.564% 1/14/2025 Marquette Asset Management LLC33,311$81K0.0%N/A0.083% 11/15/2024 XTX Topco Ltd24,716$60K0.0%+59.7%0.061% 11/15/2024 Murchinson Ltd.1,708,879$4.17M1.1%+0.5%4.239% 11/8/2024 Connor Clark & Lunn Investment Management Ltd.111,519$272K0.0%N/A0.274% 11/5/2024 BML Capital Management LLC2,186,191$5.33M3.1%+62.1%5.362% 8/16/2024 Murchinson Ltd.1,699,990$4.37M0.7%+23.2%4.184% 8/14/2024 Squarepoint Ops LLC81,758$210K0.0%-8.3%0.201% 8/14/2024 Murchinson Ltd.874,992$2.25M0.4%-36.6%2.154% 8/12/2024 XTX Topco Ltd15,474$40K0.0%N/A0.038% 8/9/2024 Renaissance Technologies LLC230,800$593K0.0%+89.0%0.568% 8/9/2024 Dimensional Fund Advisors LP31,470$81K0.0%+52.1%0.077% 5/20/2024 Virtu Financial LLC23,165$68K0.0%N/A0.057% 5/16/2024 Murchinson Ltd.1,379,495$4.03M0.3%+31.4%3.395% 4/24/2024 Assenagon Asset Management S.A.18,659$54K0.0%N/A0.046% 4/23/2024 BML Capital Management LLC844,496$2.47M1.6%-33.1%2.084% 1/30/2024 BML Capital Management LLC1,261,559$2.91M2.2%+61.5%3.127% 11/13/2023 Algert Global LLC14,680$38K0.0%N/A0.036% 11/13/2023 Rathbones Group PLC289,803$756K0.0%N/A0.718% 11/7/2023 Barclays PLC18,406$47K0.0%+39.0%0.046% 11/6/2023 N.E.W. Advisory Services LLC12,960$34K0.0%N/A0.032% 10/23/2023 BML Capital Management LLC781,292$2.04M1.9%-8.1%1.940% Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.9/21/2023 Barclays PLC13,239$47K0.0%-35.9%0.033% 8/7/2023Acadian Asset Management LLC31,736$113K0.0%N/A0.079% 7/26/2023 Glass Jacobson Investment Advisors llc12,255$44K0.0%N/A0.031% 7/24/2023 BML Capital Management LLC850,000$3.04M2.7%-37.3%2.123% 5/12/2023 Corsair Capital Management L.P.47,256$103K0.0%N/A0.119% 4/18/2023ETF Managers Group LLC68,940$150K0.0%N/A0.173% 4/14/2023 BML Capital Management LLC1,355,925$2.96M2.6%N/A3.409% 2/14/2023 683 Capital Management LLC20,537$247K0.0%N/A0.052% 2/13/2023 GSA Capital Partners LLP46,039$554K0.1%N/A0.118% 2/9/2023 Landscape Capital Management L.L.C.26,220$315K0.0%N/A0.067% 2/9/2023 Citigroup Inc.65,890$793K0.0%+115.0%0.168% 2/8/2023Belpointe Asset Management LLC29,900$360K0.0%N/A0.076% 2/8/2023 Russell Investments Group Ltd.56,516$680K0.0%N/A0.144% 2/6/2023 Glass Jacobson Investment Advisors llc9,350$112K0.1%N/A0.024% 2/1/2023Private Portfolio Partners LLC53,600$645K0.2%-20.5%0.137% 2/1/2023 Janney Montgomery Scott LLC12,379$149K0.0%N/A0.032% 1/26/2023 Calamos Advisors LLC14,746$177K0.0%N/A0.038% 1/25/2023 Lindbrook Capital LLC383,351$4.61M0.6%N/A0.980% 1/18/2023 Private Advisor Group LLC11,794$142K0.0%N/A0.030% 11/15/2022ETF Managers Group LLC94,493$612K0.0%+8.2%0.242% 11/14/2022 Cubist Systematic Strategies LLC117,477$761K0.0%+66.1%0.303% 11/14/2022Ergoteles LLC24,149$156K0.0%-89.3%0.062% 11/10/2022 Phoenix Holdings Ltd.13,634$89K0.0%-73.2%0.035% 11/7/2022 Virtu Financial LLC21,526$139K0.0%-19.3%0.055% 11/7/2022Private Portfolio Partners LLC67,400$437K0.1%+24.8%0.174% 11/3/2022 Barclays PLC21,543$140K0.0%+8.7%0.055% 10/31/2022 SG Americas Securities LLC10,370$67K0.0%-77.7%0.027% 10/21/2022Morgan Jess S & Co. Inc.366,401$2.37M2.1%+16.2%0.944% 10/17/2022 Cambridge Investment Research Advisors Inc.14,184$92K0.0%+26.8%0.037% 8/15/2022 Laurion Capital Management LP12,393$57K0.0%N/A0.032% 8/13/2022 Virtu Financial LLC26,661$122K0.0%N/A0.069% 8/11/2022 Bank of Montreal Can249,200$1.35M0.0%N/A0.646% 8/8/2022 Oppenheimer & Co. Inc.50,000$229K0.0%+5.4%0.130% 8/2/2022Private Portfolio Partners LLC54,010$247K0.1%+27.8%0.140% 7/29/2022 SG Americas Securities LLC46,532$213K0.0%N/A0.121% 7/21/2022 Belvedere Trading LLC40,690$343K0.0%N/A0.106% 7/19/2022 Commonwealth Equity Services LLC29,514$135K0.0%+7.1%0.077% 7/18/2022Morgan Jess S & Co. Inc.315,301$1.44M1.5%+8.5%0.818% 7/13/2022 Cambridge Investment Research Advisors Inc.11,184$51K0.0%N/A0.029% 6/30/2022 Amalgamated Bank6,457$56K0.0%N/A0.017% 5/16/2022Morgan Jess S & Co. Inc.290,501$2.51M1.8%+34.9%0.759% 5/12/2022Private Portfolio Partners LLC42,250$365K0.1%N/A0.110% 5/12/2022 Oppenheimer & Co. Inc.47,450$410K0.0%+18.6%0.124% 5/10/2022 Phoenix Holdings Ltd.28,155$244K0.0%-10.1%0.074% 5/9/2022 Rossmore Private Capital40,661$352K0.1%-21.8%0.106% 5/9/2022 Qube Research & Technologies Ltd56,348$487K0.0%-13.0%0.147% 5/5/2022 Russell Investments Group Ltd.43,013$371K0.0%-55.7%0.112% 5/3/2022 Calamos Advisors LLC38,071$330K0.0%-65.9%0.099% 4/25/2022 Assenagon Asset Management S.A.385,413$3.33M0.0%N/A1.007% 4/21/2022Strs Ohio5,400$46K0.0%-41.9%0.014% This Is The Moment You Betray Trump (Or Prove Them Wrong) (Ad)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to Trump’s economic plan. But now there’s a way to protect your retirement without backing down. This free 2025 Wealth Protection Guide reveals how you can use a legal IRS loophole—nicknamed “Piggy Bank”—to shield your savings.Protect your savings without betraying Trump3/3/2022 Walleye Capital LLC36,740$525K0.0%N/A0.096% 2/14/2022 Point72 Hong Kong Ltd2,132$30K0.0%N/A0.006% 2/14/2022ETF Managers Group LLC53,153$729K0.0%+6.5%0.139% 2/14/2022 Rockefeller Capital Management L.P.4,000$57K0.0%N/A0.010% 2/11/2022 Renaissance Technologies LLC203,200$2.90M0.0%N/A0.531% 2/10/2022 Qube Research & Technologies Ltd64,799$925K0.0%N/A0.169% 2/10/2022 OLD Mission Capital LLC38,691$553K0.0%N/A0.101% 2/10/2022 HighTower Advisors LLC14,000$199K0.0%-50.0%0.037% 2/10/2022 Connor Clark & Lunn Investment Management Ltd.50,786$725K0.0%+96.4%0.133% 2/9/2022 BNP Paribas Arbitrage SA20,266$289K0.0%+275.9%0.053% (Data available from 1/1/2016 forward) ORMP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ORMP shares? During the previous two years, 25 institutional investors and hedge funds held shares of Oramed Pharmaceuticals. The most heavily invested institutionals were BML Capital Management LLC ($6.46M), Murchinson Ltd. ($4.17M), Boothbay Fund Management LLC ($2.05M), Two Sigma Advisers LP ($584K), Peapod Lane Capital LLC ($540K), Rathbones Group PLC ($507K), and Bank of America Corp DE ($406K).Learn more on ORMP's institutional investors. What percentage of Oramed Pharmaceuticals stock is owned by institutional investors? 12.73% of Oramed Pharmaceuticals stock is owned by institutional investors. Learn more on ORMP's institutional investor holdings. Which institutional investors have been buying Oramed Pharmaceuticals stock? Of the 19 institutional investors that purchased Oramed Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($2.15M), Murchinson Ltd. ($658.88K), Rathbones Group PLC ($289.80K), Peapod Lane Capital LLC ($252.22K), Connor Clark & Lunn Investment Management Ltd. ($111.52K), Renaissance Technologies LLC ($108.70K), and Dimensional Fund Advisors LP ($80.96K). How much institutional buying is happening at Oramed Pharmaceuticals? Institutional investors have bought a total of 3,891,622 shares in the last 24 months. This purchase volume represents approximately $9.63M in transactions. Which Oramed Pharmaceuticals major shareholders have been selling company stock? Of the 13 institutional investors that sold Oramed Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: BML Capital Management LLC ($991.70K), Murchinson Ltd. ($504.50K), Renaissance Technologies LLC ($93.49K), Rathbones Group PLC ($53K), Squarepoint Ops LLC ($36.28K), Two Sigma Investments LP ($31.31K), and Millennium Management LLC ($22.29K). How much institutional selling is happening at Oramed Pharmaceuticals? Institutional investors have sold a total of 1,808,527 shares in the last 24 months. This volume of shares sold represents approximately $5.25M in transactions. Related Companies Oruka Therapeutics Institutional Ownership COMPASS Pathways Institutional Ownership Autolus Therapeutics Institutional Ownership Cryoport Institutional Ownership Checkpoint Therapeutics Institutional Ownership SNDL Institutional Ownership Entrada Therapeutics Institutional Ownership Olema Pharmaceuticals Institutional Ownership Arcturus Therapeutics Institutional Ownership Heron Therapeutics Institutional Ownership This page (NASDAQ:ORMP) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oramed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ORMP Stock Free ORMP Stock Alerts